Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
127.57
+0.40 (0.31%)
Nov 13, 2026, 4:00 PM EST - Market closed
Kymera Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $129 | Buy | Reiterates | $129 | +1.12% | Nov 3, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $130 → $140 | Buy | Maintains | $130 → $140 | +9.74% | Nov 2, 2026 |
| BTIG | BTIG | Buy Maintains $139 | Buy | Maintains | $139 | +8.96% | Nov 2, 2026 |
| Barclays | Barclays | Buy Maintains $139 → $170 | Buy | Maintains | $139 → $170 | +33.26% | Nov 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $146 → $150 | Buy | Reiterates | $146 → $150 | +17.58% | Oct 30, 2026 |
| RBC Capital | RBC Capital | Hold Reiterates $112 → $116 | Hold | Reiterates | $112 → $116 | -9.07% | Oct 30, 2026 |
| Citi | Citi | Buy Maintains $150 | Buy | Maintains | $150 | +17.58% | Oct 30, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $151 | Buy | Maintains | $151 | +18.37% | Oct 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.